Recent studies have shown that CXCR4 mutations and WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis syndrome) mutations enhance tumor dissemination and extramedullary involvement within xenograft mouse models of WM [16, 17]. The gene discussed is CXCR4; the disease is neoplasm.